Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05426096 · ClinicalTrials.gov registry record · NA
Comparison of Intraoperative Best Practice Advisory Reminders to Protocolize Insulin Administration Versus Standard Care in Patients at High Risk of Hyperglycemia
A NA study, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 7,232
- Enrollment target
NCT05426096: Completed NA study, sponsored by Vanderbilt University Medical Center.
NCT05426096 is a NA study that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 7,232 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (415% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05426096, a NA study, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 7,232 participants
- Enrollment target
Study Summary
This study will assess the implementation of a glucose management clinical decision support tool. The specific objective is to determine if supplementing the existing glucose check reminder with a best practice advisory (BPA), an actionable insulin dosing calculator, providers will be influenced to improve the control of hyperglycemia.
Primary Outcome
Frequency of hyperglycemia (glucose \>180 mg/dL) at first Post Anesthesia Care Unit (PACU) measurement.
Interventions
- OTHER Best Practice Advisory
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,232 participants |
| Start Date | 2022-10-05 |
| Est. Completion | 2023-10-05 |
| Phase | NA |
What the finished NCT05426096 record still lists
NCT05426096 is an interventional study that assigns participants to a tested intervention. Its 7,232 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (415% higher).
The record links to 0 conditions, and to 1 intervention - of which Best Practice Advisory is the first listed.
NCT05426096 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05426096 about?
NCT05426096 is a clinical study titled "Comparison of Intraoperative Best Practice Advisory Reminders to Protocolize Insulin Administration Versus Standard Care in Patients at High Risk of Hyperglycemia". This study will assess the implementation of a glucose management clinical decision support tool. The specific objective is to determine if supplementing the existing glucose check reminder with a best practice advisory (BPA), an actionable insulin dosing calculator, providers will be influenced to ...
What is the current status of trial NCT05426096?
This trial is currently completed. It is a NA study. The enrollment target is 7,232 participants. The study started on 2022-10-05. Estimated completion is 2023-10-05.
What interventions are being tested in trial NCT05426096?
The interventions under investigation include: Best Practice Advisory (OTHER).
Who is sponsoring clinical trial NCT05426096?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05426096's enrollment target sits among peer trials
7,232 20th of 2000 higher than 1,981 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05049837 · 7,200 participants
PROSPECT - Profiling of Resistance Patterns & Oncogenic Signaling Pathways in Evaluation of Cancers of the Thorax and Therapeutic Target Identification
- NCT06714929 · 7,200 participants · NA
Advancing Water Security: A Community Participatory School-Based Hydration Intervention
- NCT06843720 · 7,100 participants · NA
Expanding Access to Cervical Cancer Screening Through Primary HR-HPV Testing and Self-sampling: a Multicomponent Intervention for Safety Net Health Systems
- NCT02915198 · 7,410 participants · Phase 4
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI